Effectiveness of siberian fir extract used as an interferon inductor in complex therapy of acute respiratory viral infections

Objective is a study of the effectiveness and safety of using a "Florenta" dietary supplement based on Siberian fir extract as an interferon inducer in the complex therapy of acute respiratory viral infections.

Material and methods. The object of the study was a biologically active food supplement based on a concentrated aqueous extract of Siberian fir needles (Abies sibirica L.). The patients under observation were adults with various manifestations of acute respiratory viral infection (ARVI). The patients were matched in age, gender and concomitant pathology.

During the study, vital signs were monitored and tolerability and possible adverse events were recorded. The results of laboratory parameters were assessed and an overall evaluation of the effectiveness of therapy and patient satisfaction with treatment results was made.

Results. It has been established that the Siberian fir extract included into the treatment of patients with mild to moderate ARVI allows managing the clinical symptoms of the disease in a shorter time and increasing the effectiveness of complex therapy. At the same time, the risk of complications is reduced and the prognosis for the disease course becomes positive. The drug under study has been proven to be well tolerated and safe. Analysis of interferon status has revealed a significant improvement in the parameters of interferons under study.

Conclusions. As a result of the studies, it has been found out that a biologically active food supplement based on Siberian fir extract as part of complex therapy for ARVI reduces the severity and intensity of symptoms of the disease, accelerates the recovery of patients and leads to the normalization of their interferon status.